A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation

European Journal of Cardio-thoracic Surgery

Volumn 10, Issue 12, 1996, Pages 1120-1126

  Pagano, Domenico ^a   Townend, John N ^b   Horton, Richard ^a   Smith, Chris ^b   Clutton Brock, Tom ^b   Bonser, Robert S ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Heart failure; Heart transplantation; Nitric oxide; Pulmonary hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART TRANSPLANTATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG; LUNG CIRCULATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VASCULAR RESISTANCE; VASCULARIZATION; VASODILATATION;

ADMINISTRATION, INHALATION; ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EPOPROSTENOL; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; NITROPRUSSIDE; PREOPERATIVE CARE; PULMONARY CIRCULATION; SINGLE-BLIND METHOD; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0030308381     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)80360-5     Document Type: Article

References (15)

1. Anderson T, Meredith I, Ganz P, Selwyn A, Yeung A (1994) Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol 24:555-566
2. Anggard E (1994) Nitric oxide: mediator, murderer, and medicine. Lancet 343:1199-1206
3. Costard-Jackle A, Hill I, Schroeder J, Fowler M (1991) The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 84 (Suppl):329
4. Erickson K, Costanzo-Nordin M, O'Sullivan E, Johnson M, Zucker M, Pifarre' R, Lawless C, Robinson J, Scanlon P (1990) Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Lung Transplant 9:526-537
5. Fonger J, Borkon M, Baumgartner W, Achuff S, Augustine S, Reitz B (1986) Acute right ventricular failure following heart transplantation: improvement with prostaglandin E1 and right ventricular assist. J Heart Transplant 5:317-321
6. Frostell C, Fratacci M, Wain J, Zapol W (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047
7. Frostell C, Blomqvist H, Hedenstierna G, Lundberg J, Zapol W (1993) Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilatation. Anaesthesiology 78:427-435
8. Griepp R, Stinson E, Doug E, Clark D, Shumway N (1971) Determinants of operative risk in human heart transplantation. Am J Surg 122:192-197
9. Kieler-Jensen N, Ricksten S, Stenqvist O, Bergh C, Lindelov B, Wennmalm A, Waagstein F, Lundin S (1994) Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 13:366-375
10. Kirklin J, Naftel D, Kirklin J (1988) Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 7:331-336
11. Lohl E, Stamler S, Hare J, Loscalzo J, Colucci W (1994) Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction Circulation 90:2780-2785
12. Murali S, Uretsky B, Reddy S, Tokarzyk T, Betchart A (1991) Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacological agents. Am Heart J 122:1375-1381
13. Pepke-Zaba J, Higenbottam T, Dinh-Xuan A, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338:1173-1174
14. Rimar S, Gillis C (1993) Selective pulmonary vasodilatation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88:2884-2887
15. Snow D, Gray S, Ghosh S, Fuobert L, Oduro A, Higenbottam T, Wells F, Latimer R (1994) Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth 72:185-189